EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer Therapeutics

Seohyun Park, Guo-Liang Lu iD, Yi-Chao Zheng, Emma K Davison iD, Yan Li iD

Cancers · 11.08.2025 · 17 (16) · 2628

DOI: 10.3390/cancers17162628 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.08.2025. Verfasst von Seohyun Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Auckland University of Technology, Auckland 0102, New Zealand. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: School of Science, Auckland University of Technology, New Zealand, National Natural Science Foundation of China, R&D of Key Project of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistance (MDR) remains a formidable barrier to successful cancer treatment, driven by mechanisms such as efflux pump overexpression, enhanced DNA repair, evasion of apoptosis and the protective characteristics of the tumour microenvironment. Nanoparticle-based delivery systems have emerged as promising platforms capable of addressing these challenges by enhancing intracellular drug accumulation, enabling targeted delivery and facilitating stimuli-responsive and controlled release. This review provides a comprehensive overview of the molecular and cellular mechanisms underlying MDR and critically examines recent advances in nanoparticle strategies developed to overcome it. Various nanoparticle designs are analysed in terms of their structural and functional features, including surface modifications, active targeting ligands and responsiveness to tumour-specific cues. Particular emphasis is placed on the co-delivery of chemotherapeutic agents with gene regulators, such as siRNA, and the use of nanoparticles to deliver CRISPR/Cas9 gene editing tools as a means of re-sensitising resistant cancer cells. While significant progress has been made in preclinical settings, challenges such as tumour heterogeneity, limited clinical translation and immune clearance remain. Future directions include the integration of precision nanomedicine, scalable manufacturing and non-viral genome editing platforms. Collectively, nanoparticle-based drug delivery systems offer a multifaceted approach to combat MDR and hold great promise for improving therapeutic outcomes in resistant cancers.

Schlagwörter

Stichwörter der Autor:innen

ABC transportersCRISPR/Cas9 deliveryMultidrug resistance (MDR)cancer immunotherapycancer therapeuticschemoresistancedrug deliveryefflux pumpsgene editingmononuclear phagocyte systemnanocarriersnanomedicinenanoparticlesnucleic acid-based therapiesstimuli-responsive delivery

Autor:innen und Institutionen

  • School of Science, Auckland University of Technology, Auckland 0102, New Zealand.
  • Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland 0102, New Zealand.
  • Maurice Wilkins Centre, University of Auckland, Auckland 0102, New Zealand.
  • State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou University, Zhengzhou 450052, China.
  • Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou 450001, China.
  • Key Laboratory of Henan Province for Drug Quality and Evaluation, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

ORCID-Profile: Guo-Liang Lu, Emma K Davison, Yan Li

Förderung

  • School of Science, Auckland University of Technology, New Zealand
  • National Natural Science Foundation of China
  • R&D of Key Project of Henan Province
  • Auckland University of Technology Vice-Chancellor PhD Scholarship
  • R&D of Key Project of Henan Province

Zitieren

APA

Park, S., Lu, G. L., Zheng, Y. C., Davison, E. K., & Li, Y. (2025). Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer Therapeutics. Cancers, 17(16), 2628. https://doi.org/10.3390/cancers17162628

Vancouver

Park S, Lu GL, Zheng YC, Davison EK, Li Y. Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer Therapeutics. Cancers. 2025;17(16):2628. doi:10.3390/cancers17162628

BibTeX
@article{Park2025,
  author = {Park, Seohyun and Lu, Guo-Liang and Zheng, Yi-Chao and Davison, Emma K and Li, Yan},
  title = {Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer Therapeutics},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {16},
  pages = {2628},
  doi = {10.3390/cancers17162628}
}
Kostenlos starten →